Filters: keyword is Statistical [Clear All Filters]
- 2008
Pharmacokinetic/pharmacodynamic modelling of the EEG effects of opioids: the role of complex biophase distribution kinetics,
Eur J Pharm Sci, vol. 34, no. 2-3, pp. 149-63.
Pharmacokinetic-pharmacodynamic modelling of fluvoxamine 5-HT transporter occupancy in rat frontal cortex,
Br J Pharmacol, vol. 154, no. 6, pp. 1369-78.
Pharmacokinetic-pharmacodynamic modeling of the effectiveness and safety of buprenorphine and fentanyl in rats,
Pharm Res, vol. 25, no. 1, pp. 183-93.
Prediction of attack frequency in migraine treatment,
Cephalalgia, vol. 28, no. 8, pp. 847-55.
Extensions to the visual predictive check to facilitate model performance evaluation,
J Pharmacokinet Pharmacodyn, vol. 35, no. 2, pp. 185-202.
- 2007
Influence of biophase distribution and P-glycoprotein interaction on pharmacokinetic-pharmacodynamic modelling of the effects of morphine on the EEG,
Br J Pharmacol, vol. 151, no. 5, pp. 713-20.
- 2002
Mechanism-based pharmacokinetic-pharmacodynamic modeling of concentration-dependent hysteresis and biphasic electroencephalogram effects of alphaxalone in rats,
J Pharmacol Exp Ther, vol. 302, no. 3, pp. 1158-67.
- 1998
Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol,
Pharm Res, vol. 15, no. 3, pp. 442-8.
- 1988
Pharmacokinetic-pharmacodynamic modeling of midazolam effects on the human central nervous system,
Clin Pharmacol Ther, vol. 44, no. 1, pp. 14-22.



